Polycythemia Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Polycythemia stocks.

Polycythemia Stocks Recent News

Date Stock Title
Nov 19 INCY Equities Close Mostly Higher as Nvidia Jumps Ahead of Earnings; Wall Street Tracking Russia-Ukraine Conflict
Nov 19 INCY Equity Markets Close Mixed Ahead of Nvidia Earnings
Nov 19 INCY S&P 500 Gains and Losses Today: Supermicro Roars Back After Compliance Filing
Nov 19 INCY Sector Update: Health Care Stocks Decline
Nov 19 INCY Top Midday Decliners
Nov 19 INCY Equities Mixed Intraday Amid Growing Russia-Ukraine Conflict
Nov 19 INCY Incyte Pauses Enrollment in Chronic Spontaneous Urticaria Study
Nov 19 INCY Incyte seesaws on report of potential Merck takeover interest
Nov 19 INCY Incyte Stock Slumps After Firm Scraps Drug, Pauses Enrollment in Other Study
Nov 19 INCY Incyte Is the S&P 500’s Worst Performer Today. What’s Hitting the Stock.
Nov 19 INCY Incyte's $750 Million Escient Deal Faces Setback With Toxicology Issues In Two Investigational Drugs, Analyst Flags Challenges
Nov 19 INCY Incyte Faces Challenges but Remains Focused on Strategic Growth
Nov 19 INCY Incyte Collapses. Why Its $750 Million Escient Acquisition Now Looks Shattered.
Nov 19 INCY Incyte sinks on setback for drugs acquired in $750M buyout
Nov 18 INCY Incyte drops 9% after pausing enrollment in study for urticaria asset
Nov 18 INCY Incyte Provides Update on Early Phase MRGPRX2 and MRGPRX4 Programs
Nov 18 INCY Is Incyt Corporation (INCY) the Best Immunotherapy Stock to Buy Now?
Nov 16 INCY Here’s How Jakafi’s Patent Expiry Impacts Incyte Corporation’s (INCY) Growth Prospects
Polycythemia

Polycythemia (also known as polycythaemia or polyglobulia) is a disease state in which the hematocrit (the volume percentage of red blood cells in the blood) and/or hemoglobin concentration are elevated in peripheral blood.
It can be due to an increase in the number of red blood cells ("absolute polycythemia") or to a decrease in the volume of plasma ("relative polycythemia"). Polycythemia is sometimes called erythrocytosis, but the terms are not synonymous, because polycythemia refers to any increase in red blood mass (due to an erythrocytosis or not), whereas erythrocytosis only refers to a documented increase of red cell count.
The emergency treatment of polycythemia (e.g., in hyperviscosity or thrombosis) is by phlebotomy (removal of blood from the circulation). Depending on the underlying cause, phlebotomy may also be used on a regular basis to reduce the hematocrit. Myelosuppressive medications such as hydroxyurea are sometimes used for long-term management of polycythemia.

Browse All Tags